A Study to Assess the Efficacy and Safety of 20, 40, and 80mg of Sildenafil Three Times a Day in the Treatment of Pulmonary Arterial Hypertension - Related Studies

A Study to Assess the Efficacy and Safety of 20, 40, and 80mg of Sildenafil Three Times a Day in the Treatment of Pulmonary Arterial Hypertension

This study has been completed.

Study NCT00644605. Last updated on March 31, 2008. Information provided by Pfizer

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Hypertension, Pulmonary

2	Additional conditions recognized in this trial
		Hypertension

3	More general conditions related to this trial
		Cardiovascular Diseases
		Lung Diseases
		Respiratory Tract Diseases
		Vascular Diseases

4	Interventions listed in this trial
		sildenafil
		placebo

5	More general drug interventions related to this trial
		Cardiovascular Agents
		Enzyme Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Phosphodiesterase Inhibitors
		Therapeutic Uses
		Vasodilator Agents

6	Sponsors listed in this trial
		Pfizer